GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


Role of benefit-risk assessment and pharmaco-economics in decision-making of medicines


Eu2P Short Course: Role of benefit-risk assessment and pharmaco-economics in decision-making of medicines

OBJECTIVES

This course gives you an introduction into the principles and methods of comparative Benefit-Risk assessment and their role of benefit-risk assessment in decision-making of medicines.

The course provides insight in the changing health care environment and gives an overview of the different stakeholders that are involved in pharmacotherapeutic decision-making. Specific attention is given to the drivers and background of the different stakeholders and the rationale of benefit/risk and pharmacoeconomic evaluations in decision-making.

healthcare environment, process, decision-making, rational, stakeholders

 

LEARNING OUTCOMES

At the end of the course, you will :

  • Have insight in the changing healthcare environment
  • Be able to delineate the process of decision-making
  • Be able to explain the rationale of benefit-risk and pharmacoeconomic evaluation
  • Know the different stakeholders involved in the process of decision-making and be aware of the differences between key drivers of stakeholders
  • Be able to examine and demonstrate the viewpoint of a stakeholder in an example case

 

150 minutes
Online based learning
English language
Certificate of Achievement
250 € / $290
REGISTER NOW

AUTHORS

avatar

Prof. Olaf Klungel

Universiteit Utrecht

avatar

Prof. Hubert Leufkens

Universiteit Utrecht


avatar

Nasop Experts Group

ISoP's North American chapter



COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 6 30 29 00 29

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners